Behnke M, Eyler FD, Garvan CW, et al. The search for congenital malformations in newborns with fetal cocaine exposure. Pediatrics 2001; 107:E74.506 506. Addis A,Moretti ME, Ahmed Syed F, et al. Fetal effects of cocaine: an updated meta‐analysis. Reprod Toxicol 2001; 15:341.
507 507. Gouin K, Murphy K, Shah PS. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol 2011; 204:340 e1.
508 508. Hostetter A, Ritchie JC, Stowe ZN. Amniotic fluid and umbilical cord blood concentrations of antidepressants in three women. Biol Psychiatry 2000; 48:1032.
509 509. Loughhead AM, Fisher AD, Newport DJ, et al. Antidepressants in amniotic fluid: another route of fetal exposure. Am J Psychiatry 2006; 163:145.
510 510. Omtzigt JG, Nau H, Los FJ, et al. The disposition of valproate and its metabolites in the late first trimester and early second trimester of pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, co‐medication, and the presence of spina bifida. Eur J Clin Pharmacol 1992; 43:381.
511 511. Lucas BR, Latimer J, Pinto RZ, et al. Gross motor deficits in children prenatally exposed to alcohol: a meta‐analysis. Pediatrics 2014; 134:e192.
512 512. Heller M, Burd L. Review of ethanol dispersion, distribution, and elimination from the fetal compartment. Birth Defects Res A Clin Mol Teratol 2014; 100: 277.
513 513. Feeley M, Brouwer A. Health risks to infants from exposure to PCBs, PCDDs and PCDFs. Food Addit Contam 2000; 17:325.
514 514. Yamada H, Furuta I, Kato EH, et al. Maternal serum and amniotic fluid bisphenol A concentrations in the early second trimester. Reprod Toxicol 2002; 16:735.
515 515. Ikezuki Y, Tsutsumi O, Takai Y, et al. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum Reprod 2002; 17:2839.
516 516. Jedeon K, De la Dure‐Molla M, Brookes SJ, et al. Enamel defects reflect perinatal exposure to bisphenol A. Am J Pathol 2013; 183:108.
517 517. Zoeller RT, Bansal R, Parris C. Bisphenol‐A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology 2005; 146:607.
518 518. Whyatt RM, Barr DB. Measurement of organophosphate metabolites in postpartum meconium as a potential biomarker of prenatal exposure: a validation study. Environ Health Perspect 2001; 109:417.
519 519. Fennell TR, Krol WL, Sumner SC, et al. Pharmacokinetics of dibutylphthalate in pregnant rats. Toxicol Sci 2004; 82:407.
520 520. Cruger DG, Bruun‐Petersen G, Kolvraa S. Early prenatal diagnosis: standard cytogenetic analysis of coelomic cells obtained by coelocentesis. Prenat Diagn 1996; 16:945.
521 521. Elejalde BR, de Elejalde MM, Acuna JM, et al. Prospective study of amniocentesis performed between weeks 9 and 16 of gestation: its feasibility, risks, complications and use in early genetic prenatal diagnosis. Am J Med Genet 1990; 35:188.
522 522. Daniel A, Ng A, Kuah KB, et al. A study of early amniocentesis for prenatal cytogenetic diagnosis. Prenat Diagn 1998; 18:21.
523 523. Verma L, Macdonald F, Leedham P, et al. Rapid and simple prenatal DNA diagnosis of Down's syndrome. Lancet 1998; 352:9.
524 524. Pertl B, Kopp S, Kroisel PM, et al. Rapid detection of chromosome aneuploidies by quantitative fluorescence PCR: first application on 247 chorionic villus samples. J Med Genet 1999; 36:300.
525 525. Lapidot‐Lifson Y, Lebo RV, Flandermeyer RR, et al. Rapid aneuploid diagnosis of high‐risk fetuses by fluorescence in situ hybridization. Am J Obstet Gynecol 1996; 174:886.
526 526. D'Alton ME, Malone FD, Chelmow D, et al. Defining the role of fluorescence in situ hybridization on uncultured amniocytes for prenatal diagnosis of aneuploidies. Am J Obstet Gynecol 1997; 176:769; discussion 74.
527 527. Kuo WL, Tenjin H, Segraves R, et al. Detection of aneuploidy involving chromosomes 13, 18, or 21, by fluorescence in situ hybridization (FISH) to interphase and metaphase amniocytes. Am J Hum Genet 1991; 49:112.
528 528. Ried T, Landes G, Dackowski W, et al. Multicolor fluorescence in situ hybridization for the simultaneous detection of probe sets for chromosomes 13, 18, 21, X and Y in uncultured amniotic fluid cells. Hum Mol Genet 1992; 1:307.
529 529. Klinger K, Landes G, Shook D, et al. Rapid detection of chromosome aneuploidies in uncultured amniocytes by using fluorescence in situ hybridization (FISH). Am J Hum Genet 1992; 51:55.
530 530. Ward BE, Gersen SL, Carelli MP, et al. Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens. Am J Hum Genet 1993; 52:854.
531 531. Divane A, Carter NP, Spathas DH, et al. Rapid prenatal diagnosis of aneuploidy from uncultured amniotic fluid cells using five‐colour fluorescence in situ hybridization. Prenat Diagn 1994; 14:1061.
532 532. Gersen SL, Carelli MP, Klinger KW, et al. Rapid prenatal diagnosis of 14 cases of triploidy using fish with multiple probes. Prenat Diagn 1995; 15:1.
533 533. Evans MI, Henry GP, Miller WA, et al. International, collaborative assessment of 146,000 prenatal karyotypes: expected limitations if only chromosome specific probes and fluorescent in‐situ hybridization are used. Hum Reprod 1999; 14:1213.
534 534. Feldman B, Ebrahim SA, Hazan SL, et al. Routine prenatal diagnosis of aneuploidy by FISH studies in high‐risk pregnancies. Am J Med Genet 2000; 90:233.
535 535. Oneda B, Baldinger R, Reissmann R, et al. High‐resolution chromosomal microarrays in prenatal diagnosis significantly increase diagnostic power. Prenat Diagn 2014; 34:525.
536 536. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis. Obstet Gynecol 2013; 122:1374.
537 537. Brady PD, Delle Chiaie B, Christenhusz G, et al. A prospective study of the clinical utility of prenatal chromosomal microarray analysis in fetuses with ultrasound abnormalities and an exploration of a framework for reporting unclassified variants and risk factors. Genet Med 2014; 16:469.
538 538. Donnenfeld AE, Lockwood D, Custer T, et al. Prenatal diagnosis from fetal urine in bladder outlet obstruction: success rates for traditional cytogenetic evaluation and interphase fluorescence in situ hybridization. Genet Med 2002; 4:444.
539 539. Ville YG, Nicolaides KH, Campbell S. Prenatal diagnosis of fetal malformations by ultrasound. In: Milunsky A, ed. Genetic disorders and the fetus: diagnosis, prevention, and treatment. Baltimore, MD: The Johns Hopkins University Press, 2004: 836.
540 540. Golden WL, Schneider BF, Gustashaw KM, et al. Prenatal diagnosis of Turner syndrome using cells cultured from cystic hygromas in two pregnancies with normal maternal serum alpha‐fetoprotein. Prenat Diagn 1989; 9:683.
541 541. Wax JR, Blakemore KJ, Soloski MJ, et al. Fetal ascitic fluid: a new source of lymphocytes for rapid chromosomal analysis. Obstet Gynecol 1992; 80:533.
542 542. Costa D, Borrell A, Margarit E, et al. Rapid fetal karyotype from cystic hygroma and pleural effusions. Prenat Diagn 1995; 15:141.
543 543. Wald NJ, Rodeck C, Hackshaw AK, et al. First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound
